UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.37 -0.11 (-0.14%) GOLD FUTURES
2,322.50 -8.70 (-0.37%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,420.56 -329.10 (-0.65%)
LGND May 2024 65.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:10PM EDT. Market open.
| Previous close | 15.50 |
| Open | 15.50 |
| Bid | 7.20 |
| Ask | 11.00 |
| Strike | 65.00 |
| Expiry date | 2024-05-17 |
| Day's range | 15.50 - 15.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Business WireLigand Reports First Quarter 2024 Financial Results
JUPITER, Fla., May 07, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern Time to discuss this announcement and answer questions.
ZacksRocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
Rocket Pharmaceuticals' (RCKT) first-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the quarter.
ZacksApellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Apellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus Estimate and revenues beat the same, driven by strong sales of Syfovre.
© 2024 Yahoo. All rights reserved.